x
  • Advisory
    • Economic Potential Realization
    • Climate Goal Realization
    • Data and Digital Strategy Realization
    • Public Policy Realization
    • Transaction Realization
  • Solutions
    • CHOICE
    • PMIS
    • Panchlekha
    • Vidyanjali
  • Industries
    • Aerospace & Defence
    • Agriculture
    • Automotives
    • Healthcare
    • Maritime and Aviation
    • Education, Entrepreneurship, Employment
    • Tourism
    • Urban & Housing
    • Road and Railways
    • Media and Entertainment
    • Capital Market
  • Insights
    • Reports
    • Newsletters & Policy Updates
    • Op-Eds
    • Policy Square
    • Case Studies
  • Locations
    • Locations
    • India
    • UAE
    • USA
  • Careers
    • Join Us
    • Jobs
  • About
    • About us
    • Leadership
    • Diversity
    • Life At Primus
  • Media
    • Events
    • In the News
primus partners
  • Advisory
    • Economic Potential Realization
    • Climate Goal Realization
    • Data and Digital Strategy Realization
    • Public Policy Realization
    • Transaction Realization
  • Solutions
    • CHOICE
    • PMIS
    • Panchlekha
    • Vidyanjali
  • Industries
    • Aerospace & Defence
    • Agriculture
    • Automotives
    • Healthcare
    • Maritime and Aviation
    • Education, Entrepreneurship, Employment
    • Tourism
    • Urban & Housing
    • Road and Railways
    • Media and Entertainment
    • Capital Market
  • Insights
    • Reports
    • Newsletters & Policy Updates
    • Op-Eds
    • Policy Square
    • Case Studies
  • Locations
    • Locations
    • India
    • UAE
    • USA
  • Careers
    • Join Us
    • Jobs
  • About
    • About us
    • Leadership
    • Diversity
    • Life At Primus
  • Media
    • Events
    • In the News
X
  • Advisory
    Advisory
    • Economic Potential Realization
    • ESG Goal Realization
    • Data and Digital Strategy Realization
    • Public Policy Realization
    • Transaction Realization
  • Solutions
    Solutions
    • CHOICE
    • PMIS
    • Panchlekha
    • Vidyanjali
  • Industries
    Industries
    • Aerospace & Defence
    • Agriculture
    • Automotives
    • Healthcare
    • Ports & Shipping
    • Education, Entrepreneurship, Employment
    • Tourism
    • Urban & Housing
    • Road and Railways
    • Media and Entertainment
    • Capital Market
  • Insights
    Insights
    • Reports
    • Newsletters & Policy Updates
    • Op-Eds
    • Policy Square
    • Case Studies
  • Locations
    Locations
    • Locations
    • India
  • Careers
    Careers
    • Join Us
    • Jobs
  • About
    About
    • About us
    • Leadership
    • Diversity
    • Life At Primus
  • Media
    Media
    • Events
    • In the News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
Primus In News
Indian pharma ramps up US acquisitions amid regulatory and market shifts
15-03-2025

Nilaya Varma, CEO & Co-Founder, Primus Partners, and Vivek Tandon, Vice President, Primus Partners, share their view on the expansion of Indian pharmaceutical companies in the US through strategic acquisitions. They highlight Sun Pharma’s $355 million acquisition of Checkpoint Therapeutics as a key move to bolster its oncology and immunotherapy portfolio.

Explore Related Insights
  • How a Netflix bid for Warner Bros Discovery could reshape India’s entertainment landscape
  • Stock Market closing on November 10: Sensex up 319 points, Nifty closes above 25550 - What’s behind the surge?
  • More funds needed for R&D in climate-resilient seeds
  • Bajaj’s CNG bike sputters amid high costs and weak demand

Subscribe to Primus Insights and stay updated on the latest developments

  • Home
  • Careers
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
Primus Partners
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
© 2026 Primus Partners Private Limited. All Rights Reserved.